This provider's $14.0M in total Medicare payments ranks in the 93th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 10076% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1837% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $51.81 | $18.98 | 2.73x | $32.83 | $52.7K | 2.8K | 21 |
| 2015 | $63.37 | $23.82 | 2.66x | $39.55 | $1.0M | 42.9K | 32 |
| 2016 | $283.65 | $110.28 | 2.57x | $173.37 | $1.6M | 14.8K | 25 |
| 2017 | $619.48 | $152.04 | 4.07x | $467.44 | $1.8M | 11.6K | 35 |
| 2018 | $341.93 | $115.54 | 2.96x | $226.39 | $1.9M | 16.2K | 39 |
| 2019 | $90.27 | $40.51 | 2.23x | $49.76 | $994.0K | 24.5K | 49 |
| 2020 | $57.04 | $36.80 | 1.55x | $20.24 | $758.1K | 20.6K | 42 |
| 2021 | $64.44 | $36.03 | 1.79x | $28.41 | $203.2K | 5.6K | 33 |
| 2022 | $185.86 | $58.86 | 3.16x | $127.00 | $325.3K | 5.5K | 28 |
| 2023 | $37.25 | $12.16 | 3.06x | $25.09 | $5.4M | 441.3K | 37 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 433.4K | $5.1M | $11.76 | 3.06x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 19.5K | $4.5M | $232.44 | 3.28x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 19.7K | $727.3K | $36.87 | 1.28x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1.8K | $355.8K | $193.06 | 3.07x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 4.2K | $293.3K | $70.37 | 3.86x |
| G0479 | Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 3.2K | $246.8K | $77.43 | 2.58x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 2.0K | $227.3K | $112.46 | 3.33x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.5K | $226.9K | $90.77 | 1.59x |
| G6056 | Opiate(s), drug and metabolites, each procedure | 7.0K | $181.0K | $25.92 | 2.55x |
| G0431 | Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, enzyme assay), per patient encounter | 1.6K | $158.7K | $96.78 | 2.58x |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 1.6K | $117.3K | $73.18 | 1.31x |
| 87502 | Detection test by nucleic acid for multiple types influenza virus | 1.1K | $107.8K | $94.51 | 1.16x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 715 | $99.6K | $139.35 | 2.67x |
| G6031 | Benzodiazepines | 3.5K | $86.4K | $24.63 | 2.55x |
| G6042 | Amphetamine or methamphetamine | 3.5K | $72.5K | $20.70 | 2.59x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 3.6K | $67.9K | $18.76 | 3.32x |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 460 | $65.3K | $141.88 | 1.78x |
| G6046 | Dihydromorphinone | 1.8K | $62.9K | $34.22 | 2.55x |
| 80053 | Blood test, comprehensive group of blood chemicals | 5.5K | $62.7K | $11.34 | 3.52x |
| 82542 | Chemical analysis using chromatography technique | 2.6K | $61.5K | $24.05 | 2.56x |
This provider submits charges 2.93 times higher than what Medicare actually pays.
A markup ratio of 2.93x means for every $100 Medicare pays, this provider initially charges $293. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in AL for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Laboratory Corporation Of America Holdings | Birmingham, AL | $692.7M | ⚠️ Flagged |
| Eurofins Diatherix Laboratories Llc | Huntsville, AL | $37.8M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data